EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Telehealth adoption in cancer clinical trials: An Australian perspective

Emma E Thomas, Jaimon T Kelly, Monica L Taylor, Roshni Mendis, Annie Banbury, Helen Haydon, Janessa Catto, Carolyn Der Vartanian, Anthony C Smith, Liam J Caffery

Asia-Pacific Journal of Clinical Oncology · 2023-08 · 19 (4) · 549-558

DOI: 10.1111/ajco.13899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 08.12.2022. Verfasst von Emma E Thomas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Online Health, The University of Queensland, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: COVID-19, Telemedicine, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cancer clinical trials have traditionally occurred in‐person. However, the COVID‐19 pandemic has forced adaptions of all aspects of cancer care (including clinical trials) so they can be delivered remotely. We aimed to quantify and qualify current use of telehealth and how it can be further improved and routinely integrated into cancer clinical trials in Australia.

Methods

We used a mixed‐method study design, involving surveys of 14 multi‐site Collaborative Cancer Clinical Trial Groups members across Australia ( n = 98) and qualitative interviews with trial administrators and clinicians ( n = 21).

Results

The results of our study indicated a strong willingness to use telehealth for certain transactions of clinical trials because it was perceived as a way of increasing efficiency and reach of services. Hybrid models (including telehealth and in‐person methods), which considered transaction, cancer type, and patient preferences were most favorable. Additionally, telehealth allowed for greater equity to access and reduced trial burden but interestingly had little effect on increased diversity and recruitment. Factors influencing telehealth service implementation and uptake included communication among trial stakeholders, training, and learning from the experience of others in the clinical trials community.

Conclusion

Many but not all aspects of clinical trial care are appropriate to be delivered via telehealth. A hybrid approach provides flexibility to trial delivery and may support greater equity of access to trials in the future. Our findings and actionable recommendations support the need for greater planning, training, and guidelines to enable telehealth to be better integrated into clinical trials. Opportunities exist to expand the use of remote patient monitoring to enable more objective data collection from trial participants in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19TelemedicineNeoplasmsHumansAustraliaPandemics

Stichwörter der Autor:innen

COVID-19cancerclinical trialsoncologytelehealth

Autor:innen und Institutionen

  • Centre for Online Health, The University of Queensland, Brisbane, Queensland, Australia.
  • Centre for Health Services Research, The University of Queensland, Brisbane, Queensland, Australia.
  • Cancer Australia, Sydney, New South Wales, Australia.
  • Centre for Innovative Medical Technology, University of Southern Denmark, Odense, Denmark.

Förderung

  • Cancer Australia

Zitieren

APA

Thomas, E. E., Kelly, J. T., Taylor, M. L., Mendis, R., Banbury, A., Haydon, H., Catto, J., Der Vartanian, C., Smith, A. C., & Caffery, L. J. (2023). Telehealth adoption in cancer clinical trials: An Australian perspective. Asia-Pacific Journal of Clinical Oncology, 19(4), 549-558. https://doi.org/10.1111/ajco.13899

Vancouver

Thomas EE, Kelly JT, Taylor ML, Mendis R, Banbury A, Haydon H, et al. Telehealth adoption in cancer clinical trials: An Australian perspective. Asia-Pacific Journal of Clinical Oncology. 2023;19(4):549-558. doi:10.1111/ajco.13899

BibTeX
@article{Thomas2023,
  author = {Thomas, Emma E and Kelly, Jaimon T and Taylor, Monica L and Mendis, Roshni and Banbury, Annie and Haydon, Helen and Catto, Janessa and Der Vartanian, Carolyn and Smith, Anthony C and Caffery, Liam J},
  title = {Telehealth adoption in cancer clinical trials: An Australian perspective},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2023},
  volume = {19},
  number = {4},
  pages = {549--558},
  doi = {10.1111/ajco.13899}
}
Kostenlos starten →